Trial Profile
Safety and Efficacy of LUMIGAN RC Versus DuoTrav in Patients Who Require Further Intraocular Pressure (IOP) Reduction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary) ; Travoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Allergan
- 13 Apr 2015 New trial record